Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer. | Front Cell Dev Biol | 2023 | 37779899 | PubTator, text mining | PubMed |
| Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies. | Transl Oncol | 2023 | 37776617 | PubTator, text mining | PubMed |
| ROR1-AS1 might promote in vivo and in vitro proliferation and invasion of cholangiocarcinoma cells. | BMC Cancer | 2023 | 37770853 | PubTator, text mining | PubMed |
| Atypical Chronic Lymphocytic Leukemia-The Current Status. | Cancers (Basel) | 2023 | 37760396 | PubTator, text mining | PubMed |
| Targeting Breast Cancer: The Familiar, the Emerging, and the Uncharted Territories. | Biomolecules | 2023 | 37759706 | PubTator, text mining | PubMed |
| MBMethPred: a computational framework for the accurate classification of childhood medulloblastoma subgroups using data integration and AI-based approaches. | Front Genet | 2023 | 37745846 | PubTator, text mining | PubMed |
| ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype. | Front Oncol | 2023 | 37719008 | PubTator, text mining | PubMed |
| Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma. | NPJ Precis Oncol | 2023 | 37717087 | PubTator, text mining | PubMed |
| Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges. | Front Pharmacol | 2023 | 37711177 | PubTator, text mining | PubMed |
| Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment. | Sci Rep | 2023 | 37704696 | PubTator, text mining | PubMed |
| Rho family small GTPase Rif regulates Wnt5a-Ror1-Dvl2 signaling and promotes lung adenocarcinoma progression. | J Biol Chem | 2023 | 37703992 | PubTator, text mining | PubMed |
| Update on immune-based therapy strategies targeting cancer stem cells. | Cancer Med | 2023 | 37698048 | PubTator, text mining | PubMed |
| Zanubrutinib: past, present, and future. | Blood Cancer J | 2023 | 37696810 | PubTator, text mining | PubMed |
| A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers. | Int J Mol Sci | 2023 | 37686122 | PubTator, text mining | PubMed |
| Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease. | Transl Neurodegener | 2023 | 37667404 | PubTator, text mining | PubMed |
| Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications. | Front Immunol | 2023 | 37662949 | PubTator, text mining | PubMed |
| Role of Resistin in Various Diseases with Special Emphasis on Periodontal and Periapical Inflammation - A Review. | J Pharm Bioallied Sci | 2023 | 37654317 | PubTator, text mining | PubMed |
| Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects. | Front Immunol | 2023 | 37649478 | PubTator, text mining | PubMed |
| Cellular Therapy in NSCLC: Between Myth and Reality. | Curr Oncol Rep | 2023 | 37646900 | PubTator, text mining | PubMed |
| Recent advances in targeted strategies for triple-negative breast cancer. | J Hematol Oncol | 2023 | 37641116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=15